TrialThe Journal of urology2025

The Efficacy and Safety Between Intradetrusor OnabotulinumtoxinA Injection and Combined Pharmacotherapy in Patients With Refractory Overactive Bladder: A Randomized Controlled Trial.

Meng-Hsuen Hsieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.